Abstract
Diabetes Mellitus and obesity, now coined as “Diabesity”, is a worldwide
epidemic that imposes a huge burden on healthcare and society. Diabesity has been
associated with poor outcomes and increased morbidity and mortality. The kidneys are
a vulnerable target of diabesity. In this chapter, we discuss the epidemiology,
pathophysiology, and treatment of diabesity–induced kidney disease. We specifically
focus on the therapeutic targets and pharmacological management of diabesity-related
kidney diseases.
Keywords: Chronic kidney disease, Diabesity, Diabetes, Diabetic kidney disease, Kidney failure, Obesity.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Aging Science
Anti-Infective Agents
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents